NovaBridge Biosciences American Depositary Shares
NBP
47 hedge funds and large institutions have $20.1M invested in NovaBridge Biosciences American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 12 closing their positions.
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1.79% less ownership
Funds ownership: 9.74% → 7.95% (-1.8%)
2% less funds holding
Funds holding: 48 → 47 (-1)
36% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 14
39% less call options, than puts
Call options by funds: $11K | Put options by funds: $18K
64% less capital invested
Capital invested by funds: $55.9M → $20.1M (-$35.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.22M |
| 2 |
Morgan Stanley
New York
|
+$1.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$282K |
| 4 |
Jane Street
New York
|
+$279K |
| 5 |
Two Sigma Investments
New York
|
+$256K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.32M |
| 2 |
BlackRock
New York
|
-$2.93M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.4M |
| 4 |
State Street
Boston,
Massachusetts
|
-$894K |
| 5 |
Renaissance Technologies
New York
|
-$401K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
| – | -$93.6K | -31,837 | Closed |
|
|
CANY
52
Caxton Associates (New York)
New York
| – | -$75.1K | -25,132 | Closed |
|
|
VIA
53
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$32K | -10,693 | Closed |
|
54
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$6.83K | -2,284 | Closed |
|
55
Fisher Asset Management
Camas,
Washington
| – | -$2.57K | -861 | Closed |
|
56
Citadel Advisors
Miami,
Florida
| – | -$1.06K | -485 | Closed |
|
57
Osaic Holdings
Scottsdale,
Arizona
| – | -$8 | -3 | Closed |
|
NBP Hedge Fund Activity: Q3 2023 in Review
47 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2023, worth a combined $20.1M — down 64% from $55.9M a quarter earlier.
Fund positioning in NBP was balanced in Q3 2023: 12 funds opened new positions, 12 closed out, 9 added to existing stakes and 14 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.22M. The largest seller was Vanguard Group, exiting entirely with an estimated $6.32M sold.
- 47 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2023, down from 48 in Q2 2023.
- Funds reported $20.1M of NovaBridge Biosciences American Depositary Shares stock for Q3 2023, down 64% quarter-over-quarter.
- 12 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2023 and 12 closed out, a net change of 0 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2023 was Millennium Management, an estimated $1.22M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2023 was Vanguard Group, an estimated $6.32M sold.
Based on aggregated 13F filings for Q3 2023.